196 related articles for article (PubMed ID: 17481690)
21. Solution structure and functional characterization of SGTx1, a modifier of Kv2.1 channel gating.
Lee CW; Kim S; Roh SH; Endoh H; Kodera Y; Maeda T; Kohno T; Wang JM; Swartz KJ; Kim JI
Biochemistry; 2004 Feb; 43(4):890-7. PubMed ID: 14744131
[TBL] [Abstract][Full Text] [Related]
22. Effects and mechanism of gating modifier spider toxins on the hERG channel.
Wang Y; Luo Z; Lei S; Li S; Li X; Yuan C
Toxicon; 2021 Jan; 189():56-64. PubMed ID: 33212100
[TBL] [Abstract][Full Text] [Related]
23. Solution structure of hanatoxin1, a gating modifier of voltage-dependent K(+) channels: common surface features of gating modifier toxins.
Takahashi H; Kim JI; Min HJ; Sato K; Swartz KJ; Shimada I
J Mol Biol; 2000 Mar; 297(3):771-80. PubMed ID: 10731427
[TBL] [Abstract][Full Text] [Related]
24. Solution structure of Phrixotoxin 1, a specific peptide inhibitor of Kv4 potassium channels from the venom of the theraphosid spider Phrixotrichus auratus.
Chagot B; Escoubas P; Villegas E; Bernard C; Ferrat G; Corzo G; Lazdunski M; Darbon H
Protein Sci; 2004 May; 13(5):1197-208. PubMed ID: 15096626
[TBL] [Abstract][Full Text] [Related]
25. Solution structure of GxTX-1E, a high-affinity tarantula toxin interacting with voltage sensors in Kv2.1 potassium channels .
Lee S; Milescu M; Jung HH; Lee JY; Bae CH; Lee CW; Kim HH; Swartz KJ; Kim JI
Biochemistry; 2010 Jun; 49(25):5134-42. PubMed ID: 20509680
[TBL] [Abstract][Full Text] [Related]
26. Molecular surface of JZTX-V (β-Theraphotoxin-Cj2a) interacting with voltage-gated sodium channel subtype NaV1.4.
Luo J; Zhang Y; Gong M; Lu S; Ma Y; Zeng X; Liang S
Toxins (Basel); 2014 Jul; 6(7):2177-93. PubMed ID: 25055801
[TBL] [Abstract][Full Text] [Related]
27. Two tarantula peptides inhibit activation of multiple sodium channels.
Middleton RE; Warren VA; Kraus RL; Hwang JC; Liu CJ; Dai G; Brochu RM; Kohler MG; Gao YD; Garsky VM; Bogusky MJ; Mehl JT; Cohen CJ; Smith MM
Biochemistry; 2002 Dec; 41(50):14734-47. PubMed ID: 12475222
[TBL] [Abstract][Full Text] [Related]
28. Pharmacological characterization of potent and selective NaV1.7 inhibitors engineered from Chilobrachys jingzhao tarantula venom peptide JzTx-V.
Moyer BD; Murray JK; Ligutti J; Andrews K; Favreau P; Jordan JB; Lee JH; Liu D; Long J; Sham K; Shi L; Stöcklin R; Wu B; Yin R; Yu V; Zou A; Biswas K; Miranda LP
PLoS One; 2018; 13(5):e0196791. PubMed ID: 29723257
[TBL] [Abstract][Full Text] [Related]
29. Jingzhaotoxin-II, a novel tarantula toxin preferentially targets rat cardiac sodium channel.
Wang M; Liu Q; Luo H; Li J; Tang J; Xiao Y; Liang S
Biochem Pharmacol; 2008 Dec; 76(12):1716-27. PubMed ID: 18840410
[TBL] [Abstract][Full Text] [Related]
30. Jingzhaotoxin-III, a novel spider toxin inhibiting activation of voltage-gated sodium channel in rat cardiac myocytes.
Xiao Y; Tang J; Yang Y; Wang M; Hu W; Xie J; Zeng X; Liang S
J Biol Chem; 2004 Jun; 279(25):26220-6. PubMed ID: 15084603
[TBL] [Abstract][Full Text] [Related]
31. Expression and characterization of jingzhaotoxin-34, a novel neurotoxin from the venom of the tarantula Chilobrachys jingzhao.
Chen J; Zhang Y; Rong M; Zhao L; Jiang L; Zhang D; Wang M; Xiao Y; Liang S
Peptides; 2009 Jun; 30(6):1042-8. PubMed ID: 19463735
[TBL] [Abstract][Full Text] [Related]
32. Function and solution structure of hainantoxin-I, a novel insect sodium channel inhibitor from the Chinese bird spider Selenocosmia hainana.
Li D; Xiao Y; Hu W; Xie J; Bosmans F; Tytgat J; Liang S
FEBS Lett; 2003 Dec; 555(3):616-22. PubMed ID: 14675784
[TBL] [Abstract][Full Text] [Related]
33. [Inhibition of Jingzhaotoxin-V on Kv4.3 channel].
Cai LJ; Xu DH; Luo J; Chen RZ; Chi YP; Zeng XZ; Wang XC; Liang SP
Sheng Li Xue Bao; 2010 Jun; 62(3):255-60. PubMed ID: 20571743
[TBL] [Abstract][Full Text] [Related]
34. Mutational analysis of ProTx-I and the novel venom peptide Pe1b provide insight into residues responsible for selective inhibition of the analgesic drug target Na
Rupasinghe DB; Herzig V; Vetter I; Dekan Z; Gilchrist J; Bosmans F; Alewood PF; Lewis RJ; King GF
Biochem Pharmacol; 2020 Nov; 181():114080. PubMed ID: 32511987
[TBL] [Abstract][Full Text] [Related]
35. Purification and Characterization of JZTx-14, a Potent Antagonist of Mammalian and Prokaryotic Voltage-Gated Sodium Channels.
Zhang J; Tang D; Liu S; Hu H; Liang S; Tang C; Liu Z
Toxins (Basel); 2018 Oct; 10(10):. PubMed ID: 30308978
[TBL] [Abstract][Full Text] [Related]
36. Solution structure of BmKK2, a new potassium channel blocker from the venom of chinese scorpion Buthus martensi Karsch.
Zhang N; Li M; Chen X; Wang Y; Wu G; Hu G; Wu H
Proteins; 2004 Jun; 55(4):835-45. PubMed ID: 15146482
[TBL] [Abstract][Full Text] [Related]
37. Molecular Interactions between Tarantula Toxins and Low-Voltage-Activated Calcium Channels.
Salari A; Vega BS; Milescu LS; Milescu M
Sci Rep; 2016 Apr; 6():23894. PubMed ID: 27045173
[TBL] [Abstract][Full Text] [Related]
38. Solution structure of omega-grammotoxin SIA, a gating modifier of P/Q and N-type Ca(2+) channel.
Takeuchi K; Park E; Lee C; Kim J; Takahashi H; Swartz K; Shimada I
J Mol Biol; 2002 Aug; 321(3):517-26. PubMed ID: 12162963
[TBL] [Abstract][Full Text] [Related]
39. Structural basis of binding and inhibition of novel tarantula toxins in mammalian voltage-dependent potassium channels.
Shiau YS; Huang PT; Liou HH; Liaw YC; Shiau YY; Lou KL
Chem Res Toxicol; 2003 Oct; 16(10):1217-25. PubMed ID: 14565763
[TBL] [Abstract][Full Text] [Related]
40. Tarantula toxins use common surfaces for interacting with Kv and ASIC ion channels.
Gupta K; Zamanian M; Bae C; Milescu M; Krepkiy D; Tilley DC; Sack JT; Yarov-Yarovoy V; Kim JI; Swartz KJ
Elife; 2015 May; 4():e06774. PubMed ID: 25948544
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
